Headline
The latest stories from AHA Today.
The National Academies of Science, Engineering and Medicine released A Framework for Equitable Allocation of Vaccine for the Novel Coronavirus to assist and guide the federal government and decision-making bodies, including the Advisory Committee on Immunization Practices, as well as state, tribal…
Department of Health and Human Services Secretary Alex Azar announced the renewal of the COVID-19 national public health emergency declaration.
In part two of this podcast series, Elisa Arespacochaga, vice president of the AHA Physician Alliance, speaks with Chris Moriates, M.D., assistant dean for health care value at the University of Texas at Austin Dell Medical School, and Pamela Johnson, M.D., vice president of care transformation at…
State Medicaid programs must cover medication assisted treatment under a new mandatory benefit.
The AHA responded to a Centers for Medicare & Medicaid Services request for information regarding whether the agency should include exceptions to the electronic prescribing of controlled substances requirements in the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment…
The Department of Health and Human Services Assistant Secretary for Preparedness and Response has released a recording of its Sept. 24 webinar on strategies to optimize personal protective equipment and supplies during the COVID-19 public health emergency.
A vast majority of nurse leaders (86%) feel prepared for a future COVID-19 surge, according to more than 1,800 nurse leaders the AHA’s American Organization for Nursing Leadership surveyed in July about pandemic preparedness and other key issues.
The Department of Health and Human Services’ Office of the Assistant Secretary for Preparedness and Response awarded to Denver Health and Hospital Authority a $3 million cooperative agreement to demonstrate how a Regional Disaster Health Response System could improve medical surge and specialty…
The Food and Drug Administration posted updated comparative performance data for molecular tests to diagnose the COVID-19 virus.
Beginning October 1, American hospitals can purchase Veklury (remdesivir) directly from the drug’s distributor, the Department of Health and Human Services announced today.